2018 ASCO Annual Meeting

Arnaud Mejean, MD, PhD, Hôpital Européen Georges-Pompidou - Paris Descartes University, presenting LBA3, Nephrectomy is not anymore the standard of care in metastatic renal cell carcinoma (mRCC) : results from Carmena trial (NCT00930033), during Plenary Press Briefing

Chicago, IL - 2018 ASCO Annual Meeting - Arnaud Mejean, MD, PhD, Hôpital Européen Georges-Pompidou - Paris Descartes University, presenting LBA3, Nephrectomy is not anymore the standard of care in metastatic renal cell carcinoma (mRCC) : results from Carmena trial (NCT00930033), during Plenary Press Briefing at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Sunday June 3, 2018. Approximately 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 54th Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epidemiological studies. Photo by © ASCO/Zach Boyden-Holmes 2018 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org